10.1146/annurev-bioeng-071811-150124 82
Insulin sensitivity pilot study (Ruggenenti): A pilot study in nondiabetic subjects at increased cardiovascular risk with insulin resistance found that 2 g/day of oral ALCAR for 6 months improved insulin-mediated glucose disposal (measured by euglycemic hyperinsulinemic clamp) alongside reductions in blood pressure [5][21]
In the Phase 2 trial published in the New England Journal of Medicine in 2023, the most common side effects were gastrointestinal and dose-related, mostly mild to moderate
It remains active for about a week after each injection
However, research shows that combining weight loss with adequate protein, calcium, vitamin D, and weight-bearing exercise can help preserve bone density
Regulation of the Pentose Phosphate Pathway The major regulator of the PPP is the cellular response to oxidative stress